Sutureless Scleral Fixation of IOLS

Evaluating real-world outcomes.

Zachary Zavodni, MD

Cataract and Refractive Surgery Today

Double-Flanged Polypropylene Technique: 5-Year Results Canabrava S, Carvalho MS1Industry support: None ABSTRACT SUMMARY A prospective observational case series evaluated the outcomes of patients who underwent the flanged polypropylene scleral fixation of capsular tension segments (CTSs) and IOLs. A total of 71 eyes were divided into three groups: double-flanged CTS (n = 25), four-flanged nonfoldable IOL (n = 18), and four-flanged foldable IOL (n = 28). The sutures made of 5-0 and 6-0 polypropylene were used in 60% and 40% of the cases, respectively. Partial-thickness scleral tunnels were created in all cases to facilitate burial of the flanges. Follow-up averaged 28.24 months (range, 6–60 months). Descriptive outcome measures included patients’ visual acuity, flange position (intrascleral vs sub-Tenon vs conjunctival erosion), and complications such as IOL dislocation and retinal detachment. Study in Brief A prospective observational case series assessed the long-term results and complications of the scleral fixation of capsular tension segments and IOLs with the double-flanged polypropylene technique. Overall, fixation remained stable throughout the 5-year study period. Flange exposure or erosion occurred in less than 3% of cases. WHY IT MATTERS The double-flanged polypropylene technique has become popular for the scleral fixation of IOLs owing to its efficiency and speed.

The Future of Hyperopic LASIK: Debates and Advances

William F. Wiley, MD, and Wesam Silk, MD

Eyetube

In this episode of CRST: The Podcast, host William F. Wiley, MD, and Wesam Silk, MD, take a deep dive into the evolving world of hyperopic LASIK and its alternatives. They explore the technological advances that have reshaped the treatment of hyperopia, examine the shift toward lens-based solutions, and speculate about future innovations in refractive surgery. 

Adopting Remote Monitoring and AI: Lessons From Cardiology

Learning from colleagues in other medical specialties can guide ophthalmology’s smooth transition.

Judy E. Kim, MD, FARVO, FASRS, and Jagmeet P. Singh, MD, ScM, PhD, FHRS, FACC

Retina Today

AT A GLANCE The use of remote monitoring and AI is inevitable in the field of retina. However, concerns related to workflow, liability, and reimbursement hinder its adoption in day-to-day practice. Cardiology has found remote monitoring and AI to be fundamental to modern practice, benefitting both patients and providers. By learning about cardiology’s experience with adopting remote monitoring and AI in clinical practice, ophthalmologists can anticipate (and adjust for) the new era in medicine. The more ophthalmology embraces remote monitoring, the better it can meet the needs of patients and reduce treatment burden. As regulatory bodies move closer to approving home-based imaging platforms, such as home OCT and AI-based software, ophthalmologists must prepare for more data-driven care. To learn more about what this transition entails, ophthalmology can turn to other specialties with experience in widespread adoption of AI and remote monitoring. Although we practice in separate domains of medicine—retina (Dr. Kim) and cardiology (Dr. Singh)—we share a passion for improving patient care through technology.